Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer
Akaolisa Samuel Eziokwu, Leticia Varella, Megan Kruse, Xuefei Jia, Halle C. F. Moore, G. Thomas Budd, Jame Abraham, Alberto J. Montero
Topics & Concepts
MedicineLetrozoleFulvestrantPalbociclibMetastatic breast cancerInternal medicineOncologyBreast cancerHazard ratioAromatase inhibitorCancerGynecologyAromataseEstrogen receptorConfidence intervalAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysHER2/EGFR in Cancer Research